Statistics

Total Visits

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib63

Select a period of time:

Number of views in the range

Views
Clinical experience of bosutinib under compasionate use program in chronic myeloid leukemia patients with resistance or intolerance to imatinib, dasatinib and nilotinib26

Views

Views
May 20250
June 20252
July 202514
August 20250
September 20254
October 20255
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil8
Costa Rica1
Germany1
Ecuador1
United Kingdom1
Peru1
South Africa1
 

Top cities views

Views
Aracaju1
Beeville1
Brasília1
Canoas1
Chicago1
Contagem1
Dallas1
Ephrata1
Lima1
Lithonia1